Mirae Asset Global ETFs Holdings’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$551K Buy
14,626
+1,718
+13% +$55.6K ﹤0.01% 1843
2025
Q4
$339K Buy
12,908
+1,591
+14% +$29.2K ﹤0.01% 2092
2025
Q3
$158K Sell
11,317
-1,865
-14% -$21.3K ﹤0.01% 2447
2025
Q2
$126K Buy
13,182
+1,668
+14% +$15.8K ﹤0.01% 2490
2025
Q1
$107K Sell
11,514
-127
-1% -$1.64K ﹤0.01% 2603
2024
Q4
$162K Buy
11,641
+532
+5% +$9.65K ﹤0.01% 2485
2024
Q3
$261K Buy
11,109
+4,601
+71% +$96.6K ﹤0.01% 2234
2024
Q2
$104K Buy
+6,508
New +$112K ﹤0.01% 2543

Other funds holding TYRA

Mirae Asset Global ETFs Holdings's TYRA Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Tyra Biosciences (TYRA) stake by 13% in Q1 2026, buying an estimated $55.6K and bringing the position to 14,626 shares worth $551K. The position accounts for ﹤0.01% of the portfolio, ranked #1843.

Mirae Asset Global ETFs Holdings first reported a position in TYRA in Q2 2024 and has held it in 8 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 14,626 shares of Tyra Biosciences worth $551K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 1,718 Tyra Biosciences shares in Q1 2026, an estimated $55.6K.
  • Tyra Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1843 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Tyra Biosciences in Q2 2024 and has held it in 8 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.